Literature DB >> 2110805

Rh haemolytic disease: continuing problem of management.

D J Swinhoe1, D H Gilmore, M B McNay, M J Whittle.   

Abstract

Eighteen patients with severe Rh haemolytic disease, all of whom underwent fetal blood sampling and intrauterine transfusion, were studied. Twelve babies survived (67%) all of whom were delivered by lower segment caesarean section. There were three intrauterine deaths resulting in late abortion, one stillbirth with trisomy 21, and two neonatal deaths (both from severe prematurity). The traditional prognostic indicators were all inaccurate, and fetal blood sampling and measurement of the fetal packed cell volume were the most direct methods of assessing haemolysis. The progression of severe Rh disease is unpredictable, and we believe that all cases should be referred to specialist centres for advice or treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110805      PMCID: PMC1590144          DOI: 10.1136/adc.65.4_spec_no.365

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization.

Authors:  K H Nicolaides; M Fontanarosa; S G Gabbe; C H Rodeck
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

2.  Intense plasmapheresis in the pregnant Rh-sensitized woman.

Authors:  L C Powell
Journal:  Am J Obstet Gynecol       Date:  1968-05-15       Impact factor: 8.661

3.  Severe Rh isoimmunization--current methods of in utero diagnosis and treatment.

Authors:  J T Parer
Journal:  Am J Obstet Gynecol       Date:  1988-06       Impact factor: 8.661

4.  Antenatal fetal blood sampling for the management of alloimmunized pregnancies: effect upon maternal anti-D potency levels.

Authors:  P J Bowell; M Selinger; J Ferguson; J Giles; I Z MacKenzie
Journal:  Br J Obstet Gynaecol       Date:  1988-08

5.  Serial fetal blood sampling for the management of pregnancies complicated by severe rhesus (D) isoimmunization.

Authors:  I Z MacKenzie; P J Bowell; B M Castle; M Selinger; J F Ferguson
Journal:  Br J Obstet Gynaecol       Date:  1988-08

6.  Deaths from Rh haemolytic disease in England and Wales in 1984 and 1985.

Authors:  C A Clarke; A G Whitfield; P L Mollison
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-18

7.  A case for the antenatal administration of anti-D immunoglobulin to primigravidae.

Authors:  L A Tovey; J M Taverner
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

8.  The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions.

Authors:  C H Rodeck; K H Nicolaides; S L Warsof; W J Fysh; H R Gamsu; J R Kemp
Journal:  Am J Obstet Gynecol       Date:  1984-11-15       Impact factor: 8.661

9.  Intravascular monitoring and management of erythroblastosis fetalis.

Authors:  R L Berkowitz; U Chitkara; I A Wilkins; L Lynch; H Plosker; H H Bernstein
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

10.  Measurement of human fetoplacental blood volume in erythroblastosis fetalis.

Authors:  K H Nicolaides; W H Clewell; C H Rodeck
Journal:  Am J Obstet Gynecol       Date:  1987-07       Impact factor: 8.661

  10 in total
  1 in total

1.  Developmental outcome after intravascular intrauterine transfusion for rhesus haemolytic disease.

Authors:  G Stewart; R E Day; C Del Priore; M J Whittle; T L Turner; B M Holland
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.